Diagnosis and intervention are two key attributes of the Medical Technology market, which focuses on health problems, genetic research, and physical mobility. Thanks to its multifunctional usage and health improvement attributes, it is a vital part of the health sector – with steady growth. After revenues in the Medical Technology market had regressed in 2020 due to decreased routine medical treatments apart from COVID-19 treatments, the market came back strongly in 2021. The United States leads the sector by size followed by China with both continued with high growth rates. Due to the high demand for COVID-19 testing, the In Vitro Diagnostics segment was the outlier among the medical technology products from 2020 onwards.
industries
|
Pharma, Medical & Biotech (Healthcare)
Medical Technology
— Statista
Revenue
Select Advertising M&A Transactions
Exitwise has catalogued the most relevant M&A transactions that our industry specialized, M&A experts have completed. Feel free to search through our transaction catalogue, or better yet,Contact Usto request a list of the most relevant exits from your industry.
sold
Dadi
pharma, medical, & biotech — Medical Technology
Dadi launched in 2019 with a temperature-controlled at-home fertility test and sperm collection kit, with a mission to remind men that "infertility isn't a women's issue, it's both a men's and women's issue," according to co-founder and CEO Tom Smith.
Acquired by Ro
sold
Lively
pharma, medical, & biotech — Medical Technology
Lively's mission is to empower people with hearing loss to connect with their world through effortless technology and delightful care. Pioneering a fully virtual hearing care journey, Lively is a customer first, end-to-end audiology platform that makes it easier for users to buy advanced hearing technology with licensed professional care.
Acquired by GN Hearing
sold
Oscor
pharma, medical, & biotech — Medical Technology
Oscor Inc. designs, develops, manufactures and markets a variety of highly specialized implantable cardiac pacing and neurostimulation leads, venous access systems and diagnostic catheters, serving the cardiovascular and neurostimulation markets. Oscor has design, development and manufacturing operations in Palm Harbor, Fla, and in the Dominican Republic, and business offices in Germany, employing approximately 900 employees company-wide.
Acquired by Integer